cimetidine has been researched along with Meningitis, Meningococcal, Serogroup A in 1 studies
Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cimetidine (CIM) is an H2-receptor antagonist with a long history of clinical use in peptic ulcer disease." | 2.68 | A randomized, placebo-controlled study of oral cimetidine as an immunopotentiator of parenteral immunization with a group B meningococcal vaccine. ( Drabick, JJ; Foster, JS; Moran, EE; Tang, DB; Trofa, AF; Zollinger, WD, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drabick, JJ | 1 |
| Tang, DB | 1 |
| Moran, EE | 1 |
| Trofa, AF | 1 |
| Foster, JS | 1 |
| Zollinger, WD | 1 |
1 trial available for cimetidine and Meningitis, Meningococcal, Serogroup A
| Article | Year |
|---|---|
A randomized, placebo-controlled study of oral cimetidine as an immunopotentiator of parenteral immunization with a group B meningococcal vaccine.
Topics: Adjuvants, Immunologic; Administration, Oral; Adolescent; Adult; Antibodies, Bacterial; Bacterial Va | 1997 |